The effect of therapeutic ultrasound on smell disorder with chronic rhinoisinusitis

The effect of therapeutic pulsed ultrasound on smell disorder in adults with chronic rhinoisinusitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017050533821N1

Enrollment

Registered

2017-09-04

Start date

2017-06-16

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHRONIC RHINOSINUSITIS. •Inflammation of the paranasal sinuses that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizzine

Interventions

In treatment group? intervention was used by ultrasonic machine? ITO 750 model.

Treatment - Other

In treatment group? intervention was used by ultrasonic machine? ITO 750 model

Eligibility

Sex/Gender

All

Age

75 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 20 to 50 years? with a Chronic rhinosinusitis (diagnosis of a especial physician? clinical finding CT-scan and having symptoms such as posterior throat? cough? headache when bending forward? feeling full pressure of face and smell disorder)? No history of surgery in the nose and sinuses? Not having a malignant tumor on the face and head and mental disorders (Hallucination)? Understanding literacy and verbal power? Ability to recognize and understand at normal level? Exclusion criteria: Cold-infection in the course of treatment? Acute recurrence of rhinosinusitis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Smell disorder. Timepoint: Ten days and one month after treatment. Method of measurement: Smell identification test.;Severity of chronic rhinosinusitis symptoms. Timepoint: Ten session and one month later. Method of measurement: SNOT-20 valid qustionare.	—

Secondary

Measure	Time frame
Gender. Timepoint: First session. Method of measurement: Based on apparent phenotype.;History of disease. Timepoint: First session. Method of measurement: Ask the patient.;Affected sinuses. Timepoint: First session. Method of measurement: CT-scan.;Age. Timepoint: First session. Method of measurement: Birth cetificate information.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtieh Nazem

Faculty of Rehabilitation of Tehran University of Medical Science

naghdi@tums.ac.ir+98 21 7768 4941

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026